Sources and prices for drug-resistant tuberculosis medicines
Author:
Organization: Médecins Sans Frontières (MSF) Access Campaign and the International Union Against Tuberculosis and Lung Disease
Year: October 2013
Document Type: Report
Abstract/Summary: This report – now in its third edition – analyses the sources and prices of medicines used to treat drug-resistant tuberculosis (DR-TB), examines the key factors that shape the access environment for DR-TB medicines, reviews the research and development landscape for DR-TB treatment regimens, and makes recommendations for the way forward to reach more people and improve treatment outcomes.
Disease/Therapeutic Area: Tuberculosis
Geography:
Income Classification (World Bank):
Market Shortcomings:
Focus Areas:
Interventions:
Keywords:
]]>